1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)

BACKGROUND: SARS-CoV-2 vaccination reduces the risk and severity of coronavirus disease 2019 (COVID-19), but immunogenicity may be reduced in patients undergoing hematopoietic stem cell transplantation (HSCT). The variables that impact the humoral response, such as age, gender, disease and transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokogho, Afoke, Aleissa, Muneerah M, Chang, Jun Bai Park, Walsh, Stephen R, Crowell, Trevor A, Baden, Lindsey R, Sherman, Amy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751758/
http://dx.doi.org/10.1093/ofid/ofac492.914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751758/
http://dx.doi.org/10.1093/ofid/ofac492.914

Ejemplares similares